Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$14.3B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$7.67B |
| 3 |
Microsoft
MSFT
|
+$7.3B |
| 4 |
Apple
AAPL
|
+$7.01B |
| 5 |
NVIDIA
NVDA
|
+$4.98B |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.8% |
| 2 | Financials | 9.06% |
| 3 | Healthcare | 6.87% |
| 4 | Industrials | 6.79% |
| 5 | Consumer Discretionary | 6.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4676
Microvast
MVST
$291M
| $20.7K | ﹤0.01% |
+10,000
| New | +$7.4K |
|
|
OLPX
4677
DELISTED
Olaplex Holdings
OLPX
| $20.5K | ﹤0.01% |
+11,852
| New | +$23.6K |
|
4678
CALL
Global X Uranium ETF
URA
$6.19B
| $20.5K | ﹤0.01% |
+500
| New | +$15.3K |
|
4679
Heritage Global
HGBL
$36.8M
| $20.2K | ﹤0.01% |
+10,924
| New | +$18.4K |
|
4680
PUT
NXP Semiconductors
NXPI
$58.9B
| $19.5K | ﹤0.01% |
+100
| New | +$22.7K |
|
|
VIVS
4681
VivoSim Labs
VIVS
$1.27M
| $18.2K | ﹤0.01% |
+3,299
| New | +$16.7K |
|
|
IRD
4682
Opus Genetics
IRD
$302M
| $17.8K | ﹤0.01% |
+14,980
| New | +$17.2K |
|
4683
Atossa Therapeutics
ATOS
$23.6M
| $17.8K | ﹤0.01% |
+1,254
| New | +$24.5K |
|
|
URG
4684
Ur-Energy
URG
$564M
| $17.6K | ﹤0.01% |
+15,278
| New | +$18.9K |
|
4685
LanzaTech
LNZA
$70.1M
| $17.5K | ﹤0.01% |
+128
| New | +$19.2K |
|
|
DRRX
4686
DELISTED
DURECT Corp
DRRX
| $17.3K | ﹤0.01% |
+23,070
| New | +$25.7K |
|
4687
Lineage Cell Therapeutics
LCTX
$286M
| $17.3K | ﹤0.01% |
+34,371
| New | +$25.2K |
|
|
ORGN
4688
DELISTED
Origin Materials
ORGN
| $17.1K | ﹤0.01% |
+446
| New | +$16.9K |
|
|
ADAP
4689
DELISTED
Adaptimmune Therapeutics
ADAP
| $16.7K | ﹤0.01% |
+31,081
| New | +$22.6K |
|
|
QNRX
4690
Quoin Pharmaceuticals
QNRX
$10.8M
| $16.3K | ﹤0.01% |
+718
| New | +$16.5K |
|
4691
CEL-SCI Corp
CVM
$26M
| $16.1K | ﹤0.01% |
+1,345
| New | +$31K |
|
4692
Inuvo
INUV
$16.8M
| $15.9K | ﹤0.01% |
+2,463
| New | +$7.15K |
|
4693
Galectin Therapeutics
GALT
$315M
| $14.9K | ﹤0.01% |
+11,550
| New | +$27.7K |
|
4694
PUT
Synchrony
SYF
$25.4B
| $14.4K | ﹤0.01% |
+300
| New | +$18.4K |
|
4695
Precigen
PGEN
$2.51B
| $14.3K | ﹤0.01% |
+12,805
| New | +$10.9K |
|
4696
Dawson Geophysical
DWSN
$131M
| $14.2K | ﹤0.01% |
+10,593
| New | +$16.5K |
|
|
SOHO
4697
DELISTED
Sotherly Hotels
SOHO
| $14.1K | ﹤0.01% |
+15,150
| New | +$16.9K |
|
4698
PUT
Williams Companies
WMB
$87.9B
| $12.9K | ﹤0.01% |
+300
| New | +$16.2K |
|
4699
Ocugen
OCGN
$444M
| $12.4K | ﹤0.01% |
+15,434
| New | +$14.1K |
|
4700
Cognition Therapeutics
CGTX
$94M
| $12.3K | ﹤0.01% |
+17,500
| New | +$8.65K |
|
Similar funds
Raymond James Financial's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for Raymond James Financial, which disclosed 4,789 positions worth $271B. Its ten largest holdings account for 22% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 26,415,302 shares worth $14.2B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, followed by Financials and Healthcare.
- Raymond James Financial's largest Q4 2024 buy was Vanguard S&P 500 ETF: 26,415,302 shares worth $14.2B.
- Raymond James Financial's ten largest holdings make up 22% of its $271B portfolio in Q4 2024.
- Raymond James Financial disclosed 4,789 positions in Q4 2024, its first 13F filing on record.
Based on Raymond James Financial's 13F filing for Q4 2024, filed 6 Feb 2025.